DELIVERY ORDER

ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.

Awarded to MCKESSON CORPORATION

PIID 15B40618FTB140016US · USAspendingBiotechnology & Pharmaceuticals
-$125.1K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation-$125,116sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateSep 4, 2018
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Justice
Subagency
Federal Prison System / Bureau of Prisons
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
SAN FRANCISCO, SAN FRANCISCO, CA, 94104
Source last modified
Oct 21, 2026

Description

ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.

    US · usaspendingSource ↗
  2. Value decreased

    ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.

    US · usaspending-$125.1KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Sep 4, 2018P00001C-$125,116.41Not reportedNot reportedESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.USAspending ↗